Anthony Langone - Concepedia

Author

Anthony Langone

Vanderbilt University Medical Center ORCID

Also Known As

A Franceschi, A J Langone, A Langone, A. Langone, A.J. Langone, AJ Langone, Anthony J Langone, Anthony J. Langone, Anthony Langone, Anthony J. Langone

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Medical Center University of Maryland, Baltimore Vanderbilt University University of Minnesota University of California, Los Angeles

About

Anthony Langone is an author at Vanderbilt University Medical Center specializing in medicine, kidney transplant, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	146
2	Nephrology	4	4	126
3	Allergy	2	2	65
4	Immunology	2	2	65
5	Diabetes	1	1	27

Anthony Langone

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Cell-Free DNA and Active Rejection in Kidney Allografts Roy D. Bloom, Jonathan S. Bromberg, Emilio D. Poggio, Journal of the American Society of Nephrology	2017	539
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study James Glasbey, Adesoji Ademuyiwa, Adewale Adisa, The Lancet Oncology	2021	280
Effect of Renal Transplantation on Biomarkers of Inflammation and Oxidative Stress in End-Stage Renal Disease Patients Edith Simmons, Anthony Langone, Mehmet Tuğrul Sezer, Transplantation	2005	163
Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients Stanley C. Jordan, Suphamai Bunnapradist, Jonathan S. Bromberg, Transplantation Direct	2018	124
Switching <scp>ST</scp>udy of Kidney TRansplant <scp>PA</scp>tients with Tremor to <scp>LCP</scp>‐TacrO (<scp>STRATO</scp>): an open‐label, multicenter, prospective phase 3b study Anthony Langone, Steven M. Steinberg, Roberto Gedaly, Clinical Transplantation	2015	109
Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications Jonathan S. Bromberg, Daniel C. Brennan, Emilio D. Poggio, The Journal of Applied Laboratory Medicine	2017	84
Improvement in 3-Month Patient-Reported Gastrointestinal Symptoms After Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Paul Bolin, Bekir Tanrıöver, Gazi B. Zibari, Transplantation	2007	72
Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Renal Transplant Recipients Experiencing Gastrointestinal Intolerance: A Multicenter, Double-Blind, Randomized Study Anthony Langone, Laurence Chan, Paul Bolin, Transplantation	2011	57
Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients Bonnie Ann Sarrell, Karen C. Bloch, Alissar El Chediak, Transplant Infectious Disease	2021	48
A pilot protocol of a calcineurin‐inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function David R. Shaffer, Anthony Langone, William Nylander, Clinical Transplantation	2003	47

Page 1